| Primary |
| Hiv Infection |
76.3% |
| Drug Exposure During Pregnancy |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Cough |
1.8% |
| Diarrhoea |
1.8% |
| Dry Skin |
1.8% |
| Dyspnoea |
1.8% |
| Upper Respiratory Tract Infection |
1.8% |
| Burkitt's Lymphoma |
1.6% |
| Hypertension |
1.4% |
| Asthma |
1.2% |
| Antiviral Treatment |
1.0% |
| Foetal Exposure During Pregnancy |
1.0% |
| Ill-defined Disorder |
1.0% |
| Pathogen Resistance |
0.8% |
| Pyrexia |
0.8% |
| Gastrointestinal Disorder Therapy |
0.6% |
| Substance Use |
0.6% |
| Anal Cancer |
0.4% |
| Antifungal Prophylaxis |
0.4% |
|
| Hepatic Function Abnormal |
13.0% |
| Rash |
7.4% |
| Rhabdomyolysis |
7.4% |
| Urosepsis |
7.4% |
| Blood Creatine Phosphokinase Increased |
5.6% |
| Nephrolithiasis |
5.6% |
| Septic Shock |
5.6% |
| Acute Coronary Syndrome |
3.7% |
| Adrenal Insufficiency |
3.7% |
| Alcoholism |
3.7% |
| Blood Creatinine Increased |
3.7% |
| Cerebral Infarction |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Ectopic Pregnancy |
3.7% |
| Gamma-glutamyltransferase Increased |
3.7% |
| Liver Disorder |
3.7% |
| Maternal Exposure During Pregnancy |
3.7% |
| Neuropathy Peripheral |
3.7% |
| Pneumocystis Jiroveci Pneumonia |
3.7% |
| Premature Baby |
3.7% |
|
| Secondary |
| Hiv Infection |
55.9% |
| Product Used For Unknown Indication |
12.7% |
| Drug Exposure During Pregnancy |
11.1% |
| Antiretroviral Therapy |
2.5% |
| Antiviral Treatment |
2.5% |
| Tuberculosis |
1.7% |
| Diarrhoea |
1.6% |
| Acne |
1.2% |
| Infection Prophylaxis |
1.2% |
| Cough |
1.1% |
| Dry Skin |
1.1% |
| Dyspnoea |
1.1% |
| Upper Respiratory Tract Infection |
1.1% |
| Rash |
1.0% |
| Skin Papilloma |
1.0% |
| Atypical Mycobacterium Test Positive |
0.8% |
| Hypertension |
0.8% |
| Antiallergic Therapy |
0.7% |
| Asthma |
0.5% |
| Insomnia |
0.5% |
|
| Drug Exposure During Pregnancy |
9.1% |
| Urosepsis |
9.1% |
| Ventricular Hypertrophy |
9.1% |
| Premature Baby |
7.6% |
| Proteinuria |
7.6% |
| Abortion Spontaneous |
6.1% |
| Oedema Peripheral |
6.1% |
| Death |
4.5% |
| Maternal Drugs Affecting Foetus |
4.5% |
| Mycobacterium Avium Complex Infection |
4.5% |
| Septic Shock |
4.5% |
| Acute Coronary Syndrome |
3.0% |
| Amnesia |
3.0% |
| Arrhythmia |
3.0% |
| Blood Pressure Increased |
3.0% |
| Dermatitis Allergic |
3.0% |
| Diarrhoea |
3.0% |
| Hepatic Function Abnormal |
3.0% |
| Platelet Count Decreased |
3.0% |
| Pneumocystis Jiroveci Infection |
3.0% |
|
| Concomitant |
| Hiv Infection |
59.3% |
| Product Used For Unknown Indication |
14.9% |
| Antiretroviral Therapy |
3.3% |
| Mycobacterium Avium Complex Infection |
2.8% |
| Maternal Exposure Timing Unspecified |
2.4% |
| Prophylaxis |
2.1% |
| Drug Exposure During Pregnancy |
1.9% |
| Tuberculosis |
1.9% |
| Hepatitis B |
1.2% |
| Pneumocystis Jiroveci Pneumonia |
1.2% |
| Antifungal Prophylaxis |
0.9% |
| Asthma |
0.9% |
| Diabetes Mellitus |
0.9% |
| Hepatitis C |
0.9% |
| Nausea |
0.9% |
| Oral Candidiasis |
0.9% |
| Plasmablastic Lymphoma |
0.9% |
| Sedation |
0.9% |
| Antibiotic Prophylaxis |
0.7% |
| Cryptococcosis |
0.7% |
|
| Suicide Attempt |
10.8% |
| Nausea |
8.1% |
| Phlebitis |
8.1% |
| Abdominal Sepsis |
5.4% |
| Bone Neoplasm Malignant |
5.4% |
| Death |
5.4% |
| Foetal Exposure During Pregnancy |
5.4% |
| Gastric Cancer |
5.4% |
| Hodgkin's Disease |
5.4% |
| Injection Site Erythema |
5.4% |
| Plasmablastic Lymphoma |
5.4% |
| Platelet Count Decreased |
5.4% |
| Psychotic Disorder |
5.4% |
| Abortion Induced |
2.7% |
| Acute Myocardial Infarction |
2.7% |
| Angioedema |
2.7% |
| Anogenital Dysplasia |
2.7% |
| Anorectal Disorder |
2.7% |
| Anuria |
2.7% |
| Arrhythmia |
2.7% |
|
| Interacting |
| Hiv Infection |
53.5% |
| Hypertension |
12.8% |
| Product Used For Unknown Indication |
10.5% |
| Migraine |
7.0% |
| Blood Pressure Increased |
5.8% |
| Lipids Increased |
4.7% |
| Aspergillosis |
2.3% |
| Asthma |
1.2% |
| Herpes Simplex |
1.2% |
| Splenectomy |
1.2% |
|
| Blood Creatinine Increased |
20.0% |
| Drug Interaction |
20.0% |
| Oedema Peripheral |
20.0% |
| Renal Impairment |
20.0% |
| Cushing's Syndrome |
10.0% |
| Migraine |
10.0% |
|
